by John Conrad | Jul 10, 2024 | NewsBrief
Exciting news has emerged from the field of genetic medicine, as Jaguar Gene Therapy announces plans to initiate its first pediatric clinical trial for a novel gene therapy targeting a specific genetic form of autism spectrum disorder (ASD) and Phelan-McDermid...
by John Conrad | Jul 10, 2024 | NewsBrief
In a significant move that’s making waves across the pharmaceutical industry, AbbVie (NYSE:ABBV) has just announced a major change in its leadership team. Dr. Roopal Thakkar, a veteran of the company with over two decades of experience, has been appointed as the...
by John Conrad | Jul 10, 2024 | NewsBrief
University of Chicago researchers have made a groundbreaking discovery in the field of immunology, potentially opening up new avenues for fighting disease. In a recent study, the team identified several small molecule compounds capable of inducing “trained...
by John Conrad | Jul 9, 2024 | Policy News
The Federal Trade Commission (FTC) has released an interim report shedding light on the practices of pharmacy benefit managers (PBMs), the middlemen in the prescription drug supply chain. The report, part of an ongoing inquiry launched in 2022, raises significant...
by John Conrad | Jul 8, 2024 | NewsBrief
The heart of Illinois is set to become a global leader in biomanufacturing, thanks to a significant $51 million federal grant awarded to the Illinois Fermentation and Agriculture Biomanufacturing (iFAB) Tech Hub. This exciting development promises to transform the...
